PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer letters"
DOI: 10.1016/j.canlet.2019.10.036
Abstract: Oesophago-gastric cancers (OGCs) are aggressive tumours. While better peri-operative strategies, increased number of cytotoxic agents and availability of targeted therapies have improved survival, there remains an unmet need for novel treatment approaches. Immune checkpoint inhibitors… read more here.
Keywords: inhibitors oesophago; ogc; gastric cancers; oesophago gastric ... See more keywords